Shire PLC ORD 5P

SHP 
(LSE, Stocks) 
 

To view this page ensure that Adobe Flash Player version 10.0.0 or greater is installed.

p 4,816.95 <%= Resources.Global.txtUp %>
Updated 00:16:55
Change % 0.13% Stock price increasing
Change 6.45 Stock price increasing
Volume 0
High P 0
Low P 0
Open P 0
ISIN JE00B2QKY057
Prev close P 4,810.50
# of shares -
Market cap -
Intraday

Market closed
Shire PLC ORD 5P
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  4,816.95 5.0% Stock price increasing 9.7% Stock price increasing 4.7% Stock price increasing -5.5% Stock price decreasing 24.1% Stock price increasing
Powered by TradingView

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Merck & Company Inc (new) 65.48 0.5% Stock price increasing 4.7% Stock price increasing 6.1% Stock price increasing 3.0% Stock price increasing 29.0% Stock price increasing 11.2% Stock price increasing
 
Amgen Inc 173.14 0.8% Stock price increasing 11.9% Stock price increasing 20.0% Stock price increasing -0.7% Stock price decreasing 16.5% Stock price increasing 18.4% Stock price increasing
 
Celgene Corporation 119.44 -0.9% Stock price decreasing 6.0% Stock price increasing -1.3% Stock price decreasing 4.6% Stock price increasing 14.2% Stock price increasing 3.2% Stock price increasing
 
Gilead Sciences Inc 69.29 -0.7% Stock price decreasing -2.4% Stock price decreasing -6.9% Stock price decreasing -14.4% Stock price decreasing -22.2% Stock price decreasing -3.2% Stock price decreasing
 
Astrazeneca PLC ORD SHS $0.25 4,588.92 -2.0% Stock price decreasing 6.3% Stock price increasing 9.1% Stock price increasing -9.9% Stock price decreasing 10.8% Stock price increasing 3.4% Stock price increasing
 
BioMarin Pharmaceutical Inc 90.24 -1.4% Stock price decreasing 6.6% Stock price increasing 5.6% Stock price increasing -8.1% Stock price decreasing 15.0% Stock price increasing 8.9% Stock price increasing
 
Impax Laboratories Inc 14.70 -0.7% Stock price decreasing 22.0% Stock price increasing 6.9% Stock price increasing -38.8% Stock price decreasing -55.6% Stock price decreasing 10.9% Stock price increasing
 
H Lundbeck A/S 293.10 1.5% Stock price increasing 0.0% Stock price increasing 11.4% Stock price increasing 6.2% Stock price increasing 17.4% Stock price increasing 2.0% Stock price increasing
 
Novartis NAM SF 0,50 72.73 2.4% Stock price increasing 10.2% Stock price increasing 14.1% Stock price increasing 1.2% Stock price increasing 8.1% Stock price increasing 5.3% Stock price increasing
 
Roche Hldg AG GEN 232.20 2.5% Stock price increasing 6.7% Stock price increasing 11.2% Stock price increasing 3.4% Stock price increasing -1.3% Stock price decreasing 7.4% Stock price increasing
 
Glaxosmithkline PLC ORD 25P 1,644.83 3.2% Stock price increasing 6.4% Stock price increasing 9.4% Stock price increasing -1.2% Stock price decreasing 18.2% Stock price increasing 5.3% Stock price increasing
 
Sanofi 80.53 -0.8% Stock price decreasing 6.5% Stock price increasing 7.4% Stock price increasing 15.8% Stock price increasing 13.1% Stock price increasing 4.7% Stock price increasing
 
UCB 68.20 0.8% Stock price increasing 7.7% Stock price increasing 11.5% Stock price increasing -6.6% Stock price decreasing -7.9% Stock price decreasing 12.0% Stock price increasing
 
Biogen Inc 286.90 -2.0% Stock price decreasing 2.2% Stock price increasing -9.8% Stock price decreasing -9.4% Stock price decreasing 7.9% Stock price increasing 1.2% Stock price increasing

Company profile

Shire is a specialty biopharmaceutical company with sales focusing on ADHD drugs and orphan drugs relating to genetic disorders. Because of this latter focus the company can earn high protected margins from the competition barriers in the orphan drug sector, which also partially shields the company from patent challenges thereby reducing their operational risk.

Peers

Instruments Last Change  
Merck & Comp.. 65.48 0.1% Stock price increasing
52,76,56,86,86,25,47,60,97,71
Amgen Inc 173.14 -0.1% Stock price decreasing
27,33,11,35,33,21,47,58,98,88
Celgene Corp.. 119.44 -1.4% Stock price decreasing
69,37,15,10,13,2,3,5,4,8
Gilead Scien.. 69.29 -0.8% Stock price decreasing
100,5,11,11,14,18,32,11,50,48
Astrazeneca .. 4,588.92 0.6% Stock price increasing
12,28,37,24,13,32,18,10,9,29
BioMarin Pha.. 90.24 0.4% Stock price increasing
0,73,44,32,42,67,81,71,92,87
Impax Labora.. 14.70 0.7% Stock price increasing
50,54,45,41,29,29,25,0,45,45
Lundbeck A/S 293.10 0.0% Stock price unchanged
8,26,26,43,55,71,84,88,70,75
Novartis NAM.. 72.73 0.0% Stock price unchanged
13,26,39,29,29,38,47,76,80,75
Roche Hldg A.. 232.20 0.0% Stock price unchanged
21,43,60,69,68,75,80,93,73,85
Glaxosmithkl.. 1,644.83 0.0% Stock price decreasing
13,61,55,80,93,52,87,87,66,69
Sanofi 80.53 0.0% Stock price unchanged
83,31,12,17,21,46,47,75,82,81
UCB 68.20 0.0% Stock price unchanged
33,33,28,82,76,76,87,55,48,62
Biogen Inc 286.90 -0.7% Stock price decreasing
100,12,36,9,5,12,20,28,42,13

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 February 2017 03:52:40
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20170217.2 - EUROWEB2 - 2017-02-22 04:52:40 - 2017-02-22 03:52:40 - 1000 - Website: OKAY